Results 81 to 90 of about 945,221 (295)

Development of type 2 diabetes mellitus thirty-one years after Billroth II in a patient asking for diabetes surgery [PDF]

open access: yes, 2016
Introduction: Diabetes surgery in obese and slim patients seems to be a superior alternative to the current medical treatment. Gastric bypass is an alternative treat- ment for diabetes.
A. Reyes-Ortiz   +9 more
core  

Can medical therapy mimic the clinical efficacy or physiological effects of bariatric surgery? [PDF]

open access: yes, 2013
The number of bariatric surgical procedures performed has increased dramatically. This review discusses the clinical and physiological changes, and in particular, the mechanisms behind weight loss and glycaemic improvements, observed following the ...
le Roux, CW, Miras, AD
core   +1 more source

A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice [PDF]

open access: gold, 2020
Chloé Amouyal   +18 more
openalex   +1 more source

Type 2 diabetes remission 2 years post Roux‐en‐Y gastric bypass and sleeve gastrectomy: the role of the weight loss and comparison of DiaRem and DiaBetter scores

open access: yesDiabetic Medicine, 2017
The comparative efficacy of Roux‐en‐Y gastric bypass (RYGB) and sleeve gastrectomy on Type 2 diabetes remission and the role of weight loss are unclear.
Andrea Pucci   +20 more
semanticscholar   +1 more source

Inhibition of food intake in obese subjects by peptide YY3-36 [PDF]

open access: yes, 2003
Background: The gut hormone fragment peptide YY3-36 (PYY) reduces appetite and food intake when infused into subjects of normal weight. In common with the adipocyte hormone leptin, PYY reduces food intake by modulating appetite circuits in the ...
Batterham, RL   +7 more
core   +1 more source

Effects of gastric bypass on the digestibility and postprandial metabolic fate of 15N dietary protein in rats.

open access: yesPLoS ONE
Roux-en-Y Gastric Bypass may be associated with an alteration of protein bioavailability in relation to intestinal remodeling. Our study aimed to test this hypothesis by Roux-en-Y Gastric Bypass. Diet-induced obese rats underwent Roux-en-Y Gastric Bypass
Soukaïna Benhaddou   +7 more
doaj   +1 more source

Gastric Adenocarcinoma after Gastric Bypass for Morbid Obesity: A Case Report and Review of the Literature

open access: yesCase Reports in Medicine, 2013
Gastric adenocarcinoma after gastric bypass for morbid obesity is rare but has been described. The diet restriction, weight loss, and difficult assessment of the bypassed stomach, after this procedure, hinder and delay its diagnosis. We present a 52-year-
Maxwel Capsy Boga Ribeiro   +4 more
doaj   +1 more source

Association Between Fulfilment of Expectations and Health-related Quality of Life after Gastric Bypass [PDF]

open access: yes, 2012
The objective was to examine the relationship between fulfilment of expectations and health-related quality of life 4 and 12 months after gastric bypass.
H. K. Omar   +2 more
core   +2 more sources

Increased colonic propionate reduces anticipatory reward responses in the human striatum to high-energy foods [PDF]

open access: yes, 2016
Background: Short-chain fatty acids (SCFAs), metabolites produced through the microbial fermentation of nondigestible dietary components, have key roles in energy homeostasis.
Alhabeeb, Habeeb   +14 more
core   +1 more source

Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy [PDF]

open access: hybrid, 2022
Hans Jørgen Nielsen   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy